J. Boyer

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

C. Caldas, P. Johnston, D. Longley, 2006, Cancer research.

Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan

P. Johnston, D. Longley, P. Wilson, 2004, Clinical Cancer Research.

Prostate-derived factor—a novel inhibitor of drug-induced cell death in colon cancer cells

P. Johnston, D. Longley, I. Proutski, 2009, Molecular Cancer Therapeutics.

The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to Antimetabolites

U. McDermott, T. Wilson, P. Johnston, 2004, Clinical Cancer Research.

The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells

P. Johnston, D. Longley, P. Wilson, 2007, Molecular Cancer Therapeutics.

5-Fluorouracil: identification of novel downstream mediators of tumour response.

P. Johnston, D. Longley, J. Boyer, 2004, Anticancer research.

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

P. Johnston, D. Longley, J. Boyer, 2003, Seminars in oncology.

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

U. McDermott, P. Johnston, D. Longley, 2003, Cancer research.

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

U. McDermott, P. Johnston, D. Longley, 2002, Cancer research.

Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.

P. Johnston, D. Longley, J. Boyer, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.

Miguel Martín, A. Di Leo, J. Boyer, 2017, Journal of the National Cancer Institute.